Limp

Trina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development Manager

Retrieved on: 
Wednesday, May 17, 2023
Osteoarthritis, Business development, University, Therapy, Veterinarian, Limp, Athlete, Schering-Plough, Animal, Merck, Knowledge, United, Rookie of the Year, Pharmaceutical industry

While there she was Rookie of the Year in 2021 and participated as a mentor in the Leadership Mentor Program.

Key Points: 
  • While there she was Rookie of the Year in 2021 and participated as a mentor in the Leadership Mentor Program.
  • Trina has spent the majority of her career totaling twenty-two years with Merck Animal Health in the Northeast United States.
  • Trina comes to the table with extensive knowledge and established relationships in the equine industry in her area.
  • “I am excited to join the PetVivo sales and marketing team to contribute to commercialization of life changing veterinary medical devices,” said Ms. Lally.

Mary Grace Rutland Joins PetVivo Holdings, Inc. as the Mid-Atlantic Business Development Manager

Retrieved on: 
Tuesday, April 25, 2023
Osteoarthritis, Business development, University, Therapy, Marketing, Horse, Veterinarian, Limp, Science, Athlete, Animal, Fortification, United, Management

Her love of horses took her to the University of Kentucky where she earned a degree in equine science.

Key Points: 
  • Her love of horses took her to the University of Kentucky where she earned a degree in equine science.
  • During her career, Mary Grace has held positions such as senior equine territory for Fort Dodge Animal Health, veterinary field sales manager for Neogen Corporation, and digital imaging specialist for Cuattro.
  • To further her companion animal industry experience, Mary Grace sold in-house lab analyzers for Heska Corporation and most recently was a practice growth consultant for Antech Diagnostics.
  • “I am incredibly excited to have the opportunity to join the PetVivo sales and marketing team.

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA

Retrieved on: 
Monday, April 24, 2023
Francis Marion Hotel, Osteoarthritis, Limp, Pet, American College, Sports medicine, Rehabilitation

MINNEAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the American College of Veterinary Sports Medicine and Rehabilitation (“ACVSMR”) Symposium to be held April 28th to April 29th 2023 at the Francis Marion Hotel in Charleston, South Carolina.

Key Points: 
  • MINNEAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the American College of Veterinary Sports Medicine and Rehabilitation (“ACVSMR”) Symposium to be held April 28th to April 29th 2023 at the Francis Marion Hotel in Charleston, South Carolina.
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; Spryng microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis.
  • “The ACVSMR Symposium provides us an excellent event to demonstrate to leading sports medicine and rehabilitation experts in the veterinary profession our innovative medical device, Spryng, with OsteoCushion Technology, for the management of osteoarthritis” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We welcome the opportunity to support the ACVSMR and participate in this forum to explain the benefits of Spryng and how it may be used to enhance the lives of companion animals.”
    Location: The Francis Marion Hotel in Charleston, South Carolina

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN ATLANTA, GEORGIA 

Retrieved on: 
Monday, March 27, 2023
Osteoarthritis, Westin Peachtree Plaza Hotel, Limp, Westin Hotels & Resorts, Pet, Pain management, Medical device

MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it is a Platinum Sponsor and will be exhibiting at the International Veterinary Academy of Pain Management (“IVAPM”) Pain Management Forum to be held April 2nd to April 4th 2023 at the Westin Peachtree Plaza in Atlanta, Georgia.

Key Points: 
  • MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it is a Platinum Sponsor and will be exhibiting at the International Veterinary Academy of Pain Management (“IVAPM”) Pain Management Forum to be held April 2nd to April 4th 2023 at the Westin Peachtree Plaza in Atlanta, Georgia.
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; Spryng microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis.
  • “The IVAPM Pain Management Forum provides us an excellent event to demonstrate to leading pain management experts in the veterinary profession our innovative medical device for the management of osteoarthritis, Spryng, with OsteoCushion Technology” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We welcome the opportunity to support the IVAPM and participate in this forum to explain the benefits of Spryng and how it may be used to enhance the lives of companion animals.”
    For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/
    Pain Management Forum Exhibit Details:
    Location: The Westin Peachtree Plaza in Atlanta, Georgia

Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, Montana

Retrieved on: 
Friday, March 17, 2023
Ethos, Osteoarthritis, Human, Therapy, CCL, Elastin, VOS, Cartilage, Trial of the century, Limp, Pain, Animal, Dog, Collagen, ACL, MPH, Vaccine

The dogs enrolled in this study had been diagnosed with a cranial cruciate ligament injury (similar to an ACL tear in humans).

Key Points: 
  • The dogs enrolled in this study had been diagnosed with a cranial cruciate ligament injury (similar to an ACL tear in humans).
  • There were also significant improvements in all of the other secondary clinical variables throughout the study period (lameness, osteoarthritis scoring).
  • In summary, this study demonstrates that Spryng™ may be a viable alternative for medical management of dogs with a CCL injury.
  • To view the abstract of the clinical study presented at the VOS annual conference please visit the following:

PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference

Retrieved on: 
Friday, March 10, 2023
Ethos, Benefit, Animal, Conference, VOS, Limp, Osteoarthritis, Stifle joint, Therapy, MPH, Medical device, Dog

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.
  • The VOS plays host to many of the top industry professionals involved in veterinary orthopedics.
  • Furthermore, Erik Kleemam DVM, MPH, of Ethos Veterinary Health, will be a presenter for the 2023 VOS Annual Conference in Big Sky, Montana.
  • For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/
    Location: Yellowstone Conference Center in Big Sky, Montana
    Location for Presentation: Yellowstone Conference Center, Movora Lecture Hall - Missouri Ballroom in Big Sky, Montana

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA

Retrieved on: 
Monday, February 13, 2023
Veterinarian, Mandalay Bay Convention Center, Limp, Conference, Pet, WVC, Osteoarthritis, Veterinary medicine

MINNEAPOLIS, Feb. 13, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the Western Veterinary Conference to be held February 19th to February 22nd, 2023 at the Mandalay Bay Convention Center in Las Vegas, Nevada.

Key Points: 
  • MINNEAPOLIS, Feb. 13, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the Western Veterinary Conference to be held February 19th to February 22nd, 2023 at the Mandalay Bay Convention Center in Las Vegas, Nevada.
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; Spryng microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis.
  • WVC is the largest veterinary conference that services the western part of the United States, and normally plays host to more than 15,000+ participants including many of the top industry professionals.
  • “The Western Veterinary Conference provides us an excellent event to drive forward our innovative veterinary medical device for the treatment of osteoarthritis, Spryng, with OsteoCushion Technology” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We are looking forward to the opportunity in meeting with veterinarians at the WVC to explain the benefits of Spryng and how it may be used to enhance the lives of companion animals.”
    For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/

PetVivo Reports Third Quarter of Fiscal 2023 Financial Results

Retrieved on: 
Thursday, February 9, 2023
Forgiveness, Marketing, Limp, DVM, Dog, Osteoarthritis, Horse, Marginal cost, Webcast, Conference call, Therapy, Animal, Sale, EDINA, PPP, MWI, Research, Pharmaceutical industry, Video game, Airline, Internet service provider, Conference

EDINA, MN , Feb. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023. The Company began commercialization of its lead product Spryng™ with OsteoCushion™ Technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses in September 2021.

Key Points: 
  • Conference call begins at 4:00 p.m. Central time today
    EDINA, MN , Feb. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023.
  • John Lai, CEO, commented, “I’m excited about our team’s performance in the third quarter of fiscal 2023 highlighted by revenues of $510,109 as compared to $51,004 in the same period a year ago.
  • Product shipments to MWI increased to $456,502 in the third quarter as compared to $118,264 in the second quarter of 2023.
  • In January 2023, we entered into a lease agreement for approximately 14,000 square feet of production and warehouse space in Edina, Minnesota.

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTA

Retrieved on: 
Monday, January 30, 2023
Hyatt Regency New Orleans, Limp, Osteoarthritis, Collagen, Therapy, Animal, Elastin, Cartilage, Hyatt

MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Minnesota Veterinary Medical Association Annual Meeting from February 2nd to February 4th, 2023 at the Hyatt Regency in Minneapolis, Minnesota.

Key Points: 
  • MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Minnesota Veterinary Medical Association Annual Meeting from February 2nd to February 4th, 2023 at the Hyatt Regency in Minneapolis, Minnesota.
  • Spryng is an injectable veterinary medical device comprised of millions of micronized extracellular matrix particles, which are derived from natural components, including collagen and elastin.
  • These attributes offer a great solution to manage lameness and joint afflictions, such as osteoarthritis, for companion animals in a simple in-clinic administration.
  • For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE EQUINE CONFERENCE IN INCLINE VILLAGE, NEVADA 

Retrieved on: 
Monday, January 23, 2023
Limp, Osteoarthritis, Collagen, Therapy, Animal, Elastin, Conference, Cartilage, Medical device

MINNEAPOLIS, Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Lake Tahoe Equine Conference from January 23rd to January 27th, 2023 at the Hyatt Lake Tahoe in Incline Village, Nevada.

Key Points: 
  • MINNEAPOLIS, Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Lake Tahoe Equine Conference from January 23rd to January 27th, 2023 at the Hyatt Lake Tahoe in Incline Village, Nevada.
  • "The Lake Tahoe Equine Conference is one of the premier equine veterinary conferences and a great place for us to showcase our innovative product for the management of lameness, Spryng™ with OsteoCushion™ Technology," said John Lai, Chief Executive Officer, at PetVivo Holdings, Inc. "We invite all Lake Tahoe Equine Conference attendees to stop by our PetVivo booth to learn more."
  • These attributes offer a great solution to manage lameness and joint afflictions, such as osteoarthritis, for companion animals in a simple in-clinic administration.
  • For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/